The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 2×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Interestingly, the combination of TNP+BUP doubles quit rates versus TNP+placebo [19].”
Backgroundde Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262
Nicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Self-citationBupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191 · cited 2×
“Several controlled studies of nicotine replacement therapies (NRTs) or BUP for smoking cessation or reduction have been conducted in schizophrenia [12-18].”
BackgroundResultEvins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., Freudenreich, O., Henderson, D. C., Schoenfeld, D. A., Rigotti, N. A., et al. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0b013e3180ca86fa · Cited by 179
Research works printed but not linked: 22
- Dalack, 1998, Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings, Am J Psychiatry, 155, 1490, 10.1176/ajp.155.11.1490 · DOI · Paper page
- Ziedonis, 2003, Management of smoking in people with psychiatric disorders, Curr Opin Psychiatry, 16, 305, 10.1097/01.yco.0000069086.26384.5f · DOI
- Lasser, 2000, Smoking and mental illness: A population-based prevalence study, JAMA, 284, 2606, 10.1001/jama.284.20.2606 · DOI · Paper page
- Ascher, 1995, Bupropion: A review of its mechanism of antidepressant activity, J Clin Psychiatry, 56, 395
- Ferry, 1994, Efficacy of bupropion for smoking cessation in non-depressed smokers, J Addict Dis, 13, 249
- Hurt, 1997, A comparison of sustained-release bupropion and placebo for smoking cessation, N Engl J Med, 337, 1195, 10.1056/NEJM199710233371703 · DOI · Paper page
- Addington, 1998, Smoking cessation treatment for patients with schizophrenia, Am J Psychiatry, 155, 974, 10.1176/ajp.155.7.974 · DOI · Paper page
- Chou, 2004, The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia, Int J Nurs Stud, 41, 321, 10.1016/j.ijnurstu.2003.07.001 · DOI
- Evins, 2005, A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia, J Clin Psychopharmacol, 25, 218, 10.1097/01.jcp.0000162802.54076.18 · DOI · Paper page
- Fatemi, 2005, A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia, Schizophr Res, 76, 353, 10.1016/j.schres.2005.02.021 · DOI
- George, 2000, Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia, Am J Psychiatry, 157, 1835, 10.1176/appi.ajp.157.11.1835 · DOI · Paper page
- George, 2002, A placebo-controlled study of bupropion for smoking cessation in schizophrenia, Biol Psychiatry, 52, 53, 10.1016/S0006-3223(02)01339-2 · DOI · Paper page
- Breese, 2000, Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia, Neuropsychopharmacology, 23, 351, 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
- Leonard, 2002, Promoter variants in the alpha-7 nicotinic acetylcholine receptor subunit gene are associated with an inhibitory deficit found in schizophrenia, Arch Gen Psychiatry, 59, 1085, 10.1001/archpsyc.59.12.1085 · DOI · Paper page
- Sacco, 2005, Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: Involvement of nicotinic receptor mechanisms, Arch Gen Psychiatry, 62, 649, 10.1001/archpsyc.62.6.649 · DOI · Paper page
- Biener, 1991, The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation, Health Psychol, 10, 360, 10.1037/0278-6133.10.5.360 · DOI · Paper page
- Sobell, 1988, Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations, Brit J Addict, 83, 393, 10.1111/j.1360-0443.1988.tb00485.x · DOI · Paper page
- Bland, 1998, Survival probabilities (the Kaplan-Meier method), BMJ, 317, 1572, 10.1136/bmj.317.7172.1572 · DOI · Paper page
- Hughes, 2003, Measurement of abstinence in clinical trials: issues and recommendations, Nicotine Tobacco Res, 5, 13, 10.1093/ntr/5.1.13 · DOI · Paper page
- Kapur, 1991, Use of random sequence riboflavin as a marker of medication compliance in chronic schizophrenics, Schizophr Res, 6, 49, 10.1016/0920-9964(91)90020-R · DOI
- de Leon, 2004, Atypical antipsychotic dosing: The effect of smoking and caffeine, Psychiatr Serv, 55, 491, 10.1176/appi.ps.55.5.491 · DOI
- Kotylar, 2005, Inhibition of CYP2D6 activity by bupropion, J Cin Psychopharmcol, 25, 226, 10.1097/01.jcp.0000162805.46453.e3 · DOI
Cited by
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 348
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“Two RCTs have reported that combining bupropion SR or placebo with high-dose transdermal nicotine patch resulted in higher abstinence rates than nicotine substitution alone (Evins et al., 2007; George et al., 2008) (Ib).”
Background
Metadata
- Authors
- George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 63
- Issue
- 11
- Pages
- 1092-1096
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2044741201
- Cited by
- 160
- References
- 10
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia. https://app.cochat.ai/papers/10.1016/j.biopsych.2007.11.002
- The paper
- George, T. P., Vessicchio, J. C., Sacco, K. A., Weinberger, A. H., Dudas, M. M., Allen, T. M., Creeden, C. L., Potenza, M. N., Feingold, A., & Jatlow, P. I. (2008). A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2007.11.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.